Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
resolution of basal cell carcinoma
2 years
No
Stephen B Tucker, M.D.
Principal Investigator
University of Texas Health Science Center of Houston Dermatology Clinic
United States: Institutional Review Board
HSC-MS-06-0478
NCT00581425
December 2007
September 2011
Name | Location |
---|---|
University of Texas Health Science Center of Houston Dermatology Clinic | Houston, Texas 77030 |